Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Adaptive Radiotherapy and Multimodal Information of Cervical Cancer Assisted by Artificial Intelligence

NCT04022018 is registered in ClinicalTrials.gov with The University of Hong Kong-Shenzhen Hospital as lead sponsor.

NCT NCT04022018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04022018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Adaptive Radiotherapy and Multimodal Information of Cervical Cancer Assisted by Artificial Intelligence
Lead sponsor
The University of Hong Kong-Shenzhen Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
December 18, 2019
Completion date
May 30, 2022
Enrollment
122 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

artificial intelligence, biomarker, cervical cancer, radiotherapy side effect